Disseminated gonococcal infection (DGI) is diagnosed definitively by identifying Neisseria gonorrhoeae, the bacteria that causes gonorrhea, from a non-mucosal site.
Here's a breakdown of the diagnostic process:
-
Culture or Nucleic Acid Amplification Testing (NAAT): The most reliable method is to culture N. gonorrhoeae or use NAAT to detect its genetic material from samples collected from:
- Blood: While less common, blood cultures can be positive in the early stages of DGI.
- Synovial fluid: Fluid aspirated from an infected joint is a key diagnostic sample, particularly in cases of gonococcal arthritis.
- Skin lesions: Cultures or NAAT from skin lesions associated with DGI can confirm the diagnosis.
-
Important Considerations:
-
Mucosal Site Testing: Because DGI often arises from an initial gonococcal infection at a mucosal site (e.g., urethra, cervix, rectum, pharynx), these sites should also be tested using NAAT, even if they are asymptomatic. Finding N. gonorrhoeae at a mucosal site supports the diagnosis of DGI, even if cultures from non-mucosal sites are negative (which can occur, especially after antibiotic treatment has begun).
-
Clinical Suspicion: A high index of clinical suspicion is crucial. DGI should be considered in patients presenting with:
- Fever
- Migratory polyarthralgia (pain in multiple joints)
- Tenosynovitis (inflammation of tendon sheaths)
- Dermatitis (characteristic skin lesions)
- Septic arthritis
-
Differential Diagnosis: It's important to rule out other conditions that can mimic DGI, such as other bacterial infections, viral infections, and autoimmune diseases.
-
Treatment: Empirical antibiotic treatment is often initiated based on clinical suspicion, even before definitive lab results are available, to prevent complications.
-
In summary, a confirmed diagnosis of DGI requires identification of N. gonorrhoeae from a non-mucosal site, but clinical evaluation and testing of mucosal sites are also essential to guide diagnosis and management.
